Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
about
Biomarkers for the early diagnosis of hepatocellular carcinomaProteomics based identification of cell migration related proteins in HBV expressing HepG2 cells.Novel method for extracting exosomes of hepatocellular carcinoma cells.Annexin A2 heterotetramer: structure and functionAnnexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.Annexin A2: its molecular regulation and cellular expression in cancer development.Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma.Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms.Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review)Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Biomarkers for Hepatocellular Carcinoma.Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.CSF-Based Analysis for Identification of Potential Serum Biomarkers of Neural Tube Defects.Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
P2860
Q26784418-CF8DF7F7-E879-45BD-A2CF-86B4F6CFBD36Q30009430-07BCFCED-1DC0-4BE8-853B-071DF69EF3D0Q33718359-7FC3276C-D521-4811-87C9-CAFCE570F263Q36790362-AC0EDC9B-008B-4175-B436-838CA816BDD2Q37207658-4C440200-6B21-4759-B7DA-AE00562D0FF9Q37586765-17193FC8-EED6-4FFB-8785-35E3F2300A2FQ37723978-4DD44C11-07E7-4393-B1D7-EC41F45C4128Q38375370-7AD97728-A8AE-49D3-8AD6-014DD27AA08FQ38384375-E92914C7-E2E3-49E2-96DA-8F471136A178Q38845150-C5C9FE79-E0BC-4BDA-BFBD-8A4F1DF6D64BQ38859488-4B17F48F-F29A-44E4-A022-121176164BE0Q40193396-273D6F39-9308-40BE-A448-545598FE35F5Q41921861-B97EEC55-5FB1-4F0D-BBC3-F1B2D22477ECQ42176411-E8A6DA18-554C-4D28-AB14-1232C4C8158BQ47098153-D9C8A01E-A71A-4CFB-8F51-74C90ACFDA4DQ50898153-228EF71B-6F77-4BB2-89F1-D797A908216FQ52672650-E606731E-C39B-46C4-8E39-2F86A099E7B3Q53794062-7DBA8437-CE7D-4843-85EE-6E48BEA036E3Q53836049-087F1EEF-66EB-4785-8C4B-3BF5A68D621B
P2860
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@ast
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@en
type
label
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@ast
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@en
prefLabel
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@ast
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
@en
P2093
Guangzhou Gao
Jianqiang Cai
Kaixuan Lin
Shouzhi Ma
Xiaohang Zhao
Xiaohong Qian
P2860
P304
P356
10.1093/CARCIN/BGS372
P407
P577
2012-11-27T00:00:00Z